AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC....
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC....
Two harmonics line-up here. One is threatening to cause a dead-cat bounce, while the other is much further out. The timeline is likely off by 12-to-13 days. Good luck and trade Safe!
Check it out, unload and reload near here!!!
After Aveo's swift run-up, I expect price to quickly dump to the primary support zone and gap fill/stop-hunt before pumping up again. Here, one can be patient for price to enter the potential reversal zone near the end of the gap-fill and load up. Check it out, unload and reload up!
Speaking March 10th, earnings march 16th, fda approval 31st
End of Month PDUFA date coming up. The chart itself is shaping up nicely. The drug is a very promising cancer treatment! Today (2/23) is a very red day, after half hour of trading, the low has retraced back up into the triangle. I'm thinking if I had money from other trades, I would have moved in today or tomorrow (seeing how this week pans out). Buy along...
BREAKOUT STOCK ALERT UPDATE $AVEO - AVEO Pharmaceuticals, Inc. - Common Stock Initial Alert Price: $5.43 Price High: $8.22 % Gains/Losses: 51.38% (+37% More Than Expected) Potential Stop Loss: $7.809 #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
This company is releasing data for phase one clinical trial data for a cancer treatment drug. The risk is high, but if the data is good, The stock could rise 200+%.
A very hard asset to analyze from my perspective but i do my best to build a roadmap for this asset for ASIKSAY who asked for an elliot wave count. It wasnt easy but i believe my count is the most probable count. enjoy watching me struggle at the end lol thanks rigo
Contextual immersion trading strategy idea. AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical needs. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next...
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in...
Potential trade setup developing. Alert set for break above gap fill at $6.00 Could bring a nice rally with $7.05 as a potential target. Indicators are turning bullish
Can be good chance to set-up an entry above 5 or MA50 Not for any advise Just an idea.
Trade Safe! Don`t be greedy! Take care and place small trades! If necessary, I will place more long trades at this asset! In my opinion, this stock is at a good opportunity and has good potential for the stock price to go up!
Hello, What is AVEO? AVEO Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. News My Thoughts For You There will be a little correction before we see this one moon. Wait for the pullback and monitor the daily TF for direction and 4hr for entry. When you see that the retrace is...